Cargando…
Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
As the major cause of irreversible loss of vision in adults, diabetic retinopathy (DR) is one of the most serious complications of diabetes. The imbalance of the retinal microenvironment and destruction of the blood-retinal barrier have a significant role in the progression of DR. Inward rectifying...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343704/ https://www.ncbi.nlm.nih.gov/pubmed/34373707 http://dx.doi.org/10.3892/etm.2021.10453 |
_version_ | 1783734340076699648 |
---|---|
author | Li, Xiaoyu Lv, Jiajun Li, Jiazhi Ren, Xiang |
author_facet | Li, Xiaoyu Lv, Jiajun Li, Jiazhi Ren, Xiang |
author_sort | Li, Xiaoyu |
collection | PubMed |
description | As the major cause of irreversible loss of vision in adults, diabetic retinopathy (DR) is one of the most serious complications of diabetes. The imbalance of the retinal microenvironment and destruction of the blood-retinal barrier have a significant role in the progression of DR. Inward rectifying potassium channel 4.1 (Kir4.1) is located on Müller cells and is closely related to potassium homeostasis, water balance and glutamate clearance in the whole retina. The present review discusses the functions of Kir4.1 in regulating the retinal microenvironment and related biological mechanisms in DR. In the future, Kir4.1 may represent a novel alternative therapeutic target for DR through affecting the retinal microenvironment. |
format | Online Article Text |
id | pubmed-8343704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-83437042021-08-08 Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review) Li, Xiaoyu Lv, Jiajun Li, Jiazhi Ren, Xiang Exp Ther Med Review As the major cause of irreversible loss of vision in adults, diabetic retinopathy (DR) is one of the most serious complications of diabetes. The imbalance of the retinal microenvironment and destruction of the blood-retinal barrier have a significant role in the progression of DR. Inward rectifying potassium channel 4.1 (Kir4.1) is located on Müller cells and is closely related to potassium homeostasis, water balance and glutamate clearance in the whole retina. The present review discusses the functions of Kir4.1 in regulating the retinal microenvironment and related biological mechanisms in DR. In the future, Kir4.1 may represent a novel alternative therapeutic target for DR through affecting the retinal microenvironment. D.A. Spandidos 2021-09 2021-07-15 /pmc/articles/PMC8343704/ /pubmed/34373707 http://dx.doi.org/10.3892/etm.2021.10453 Text en Copyright: © Li et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Li, Xiaoyu Lv, Jiajun Li, Jiazhi Ren, Xiang Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review) |
title | Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review) |
title_full | Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review) |
title_fullStr | Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review) |
title_full_unstemmed | Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review) |
title_short | Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review) |
title_sort | kir4.1 may represent a novel therapeutic target for diabetic retinopathy (review) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343704/ https://www.ncbi.nlm.nih.gov/pubmed/34373707 http://dx.doi.org/10.3892/etm.2021.10453 |
work_keys_str_mv | AT lixiaoyu kir41mayrepresentanoveltherapeutictargetfordiabeticretinopathyreview AT lvjiajun kir41mayrepresentanoveltherapeutictargetfordiabeticretinopathyreview AT lijiazhi kir41mayrepresentanoveltherapeutictargetfordiabeticretinopathyreview AT renxiang kir41mayrepresentanoveltherapeutictargetfordiabeticretinopathyreview |